Asia Pacific Clinical Trial Imaging Market Size & Outlook, 2025-2033

Asia Pacific Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Product (Services, Software), By Service (Clinical Trial Design and Consultation, Reading and Analytical, Operational Imaging, System and Technology Support, Project and Data Management), By Application (Nonalcoholic Steatohepatitis (NASH), Chronic Kidney Disease (CKD), Diabetes, Cardiovascular Diseases, Oncology, Neurology, Endocrinology, Dermatology, Hematology, Others), By End-Use (Biotechnology and Pharmaceutical Companies, Medical Devices Manufacturers, Academic and Government Research Institutes, Contract Research Organizations (CROs), Others), By Distributor (Direct Sales, Tender Sales) and By Country(China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2025-2033

Report Code: SRMD3244DR

Last Updated : Nov, 2022

Pages : 80

Author : Jay Mehta

Format : PDF, Excel

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

APAC

ESG Trends

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Services
  1. By Value
3. Software
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Clinical Trial Design and Consultation
  1. By Value
3. Reading and Analytical
  1. By Value
4. Operational Imaging
  1. By Value
  2. Computed Tomography (CT) Scan
    1. Computed Tomography (CT) Scan By Value
  3. MRI (Magnetic Resonance Imaging)
    1. MRI (Magnetic Resonance Imaging) By Value
  4. X-Ray
    1. X-Ray By Value
  5. Ultrasound
    1. Ultrasound By Value
  6. Optical Coherence Tomography (OCT)
    1. Optical Coherence Tomography (OCT) By Value
  7. Others
    1. Others By Value
5. System and Technology Support
  1. By Value
6. Project and Data Management
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Nonalcoholic Steatohepatitis (NASH)
  1. By Value
3. Chronic Kidney Disease (CKD)
  1. By Value
4. Diabetes
  1. By Value
5. Cardiovascular Diseases
  1. By Value
6. Oncology
  1. By Value
7. Neurology
  1. By Value
8. Endocrinology
  1. By Value
9. Dermatology
  1. By Value
10. Hematology
  1. By Value
11. Others
  1. By Value
By End-Use
1. Introduction
  1. End-Use By Value
2. Biotechnology and Pharmaceutical Companies
  1. By Value
3. Medical Devices Manufacturers
  1. By Value
4. Academic and Government Research Institutes
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value
By Distributor
1. Introduction
  1. Distributor By Value
2. Direct Sales
  1. By Value
3. Tender Sales
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Services
    1. By Value
  3. Software
    1. By Value
2. By Service
  1. Introduction
    1. Service By Value
  2. Clinical Trial Design and Consultation
    1. By Value
  3. Reading and Analytical
    1. By Value
  4. Operational Imaging
    1. By Value
    2. Computed Tomography (CT) Scan
      1. Computed Tomography (CT) Scan By Value
    3. MRI (Magnetic Resonance Imaging)
      1. MRI (Magnetic Resonance Imaging) By Value
    4. X-Ray
      1. X-Ray By Value
    5. Ultrasound
      1. Ultrasound By Value
    6. Optical Coherence Tomography (OCT)
      1. Optical Coherence Tomography (OCT) By Value
    7. Others
      1. Others By Value
  5. System and Technology Support
    1. By Value
  6. Project and Data Management
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Nonalcoholic Steatohepatitis (NASH)
    1. By Value
  3. Chronic Kidney Disease (CKD)
    1. By Value
  4. Diabetes
    1. By Value
  5. Cardiovascular Diseases
    1. By Value
  6. Oncology
    1. By Value
  7. Neurology
    1. By Value
  8. Endocrinology
    1. By Value
  9. Dermatology
    1. By Value
  10. Hematology
    1. By Value
  11. Others
    1. By Value
4. By End-Use
  1. Introduction
    1. End-Use By Value
  2. Biotechnology and Pharmaceutical Companies
    1. By Value
  3. Medical Devices Manufacturers
    1. By Value
  4. Academic and Government Research Institutes
    1. By Value
  5. Contract Research Organizations (CROs)
    1. By Value
  6. Others
    1. By Value
5. By Distributor
  1. Introduction
    1. Distributor By Value
  2. Direct Sales
    1. By Value
  3. Tender Sales
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Competitive Landscape

Asia Pacific Clinical Trial Imaging Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

IQVIA
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
PAREXEL
PPD (to be acquired by Thermo Fisher)
Syneos Health
Covance (now LabCorp Drug Development)

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment